Skip to main content

Advertisement

SpringerLink
Log in

Hypertension During Pregnancy

  • Guidelines/Clinical Trials/Meta-Analysis (WJ Kostis, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Hypertensive disorders of pregnancy affect about 5–10% of pregnancies impacting maternal, fetal, and neonatal outcomes. We review the recent studies in this field and discuss the pathophysiology, diagnosis, and management of hypertension during pregnancy, as well as the short- and long-term consequences on the cardiovascular health of women.

Recent Findings

Although the American College of Cardiology/American Heart Association revised their guidelines for hypertension in the general population in 2017, hypertension during pregnancy continues to be defined as a systolic blood pressure (SBP) ≥ 140 mmHg and/or a diastolic blood pressure (DBP) ≥ 90 mmHg, measured on two separate occasions. The addition of stage 1 hypertension will increase the prevalence of hypertension during pregnancy, identifying more women at risk of preeclampsia; however, more research is needed before changing the BP goal because a lower target BP has a risk of poor placental perfusion. Women with chronic hypertension have a higher incidence of superimposed preeclampsia, cesarean section, preterm delivery before 37 weeks’ gestation, birth weight less than 2500 g, neonatal unit admission, and perinatal death. They also have a higher risk of developing cardiovascular disease later in life. The guidelines recommend low-dose aspirin for women with moderate and high risk of preeclampsia. While treating pregnant women with hypertension, the effectiveness of the antihypertensive agent must be balanced with risks to the fetus.

Summary

Hypertensive disorders of pregnancy should be appropriately and promptly recognized and treated during pregnancy. They should further be co-managed by the obstetrician and cardiologist to decrease the long-term negative impact on the cardiovascular health of women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, de Bonis M, et al. 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165–241. https://doi.org/10.1093/eurheartj/ehy340.

    Article  PubMed  Google Scholar 

  2. Shen M, Tan H, Zhou S, Smith GN, Walker MC, Wen SW. Trajectory of blood pressure change during pregnancy and the role of pre-gravid blood pressure: a functional data analysis approach. Sci Rep. 2017;7:6227. https://doi.org/10.1038/s41598-017-06606-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. • Ananth CV, Duzyj CM, Yadava S, Schwebel M, Tita ATN, Joseph KS. Changes in the prevalence of chronic hypertension in pregnancy, United States, 1970 to 2010. Hypertension. 2019;74:1089–95. https://doi.org/10.1161/HYPERTENSIONAHA.119.12968The prevalence of chronic hypertension has been increasing over the last 4 decades, calling for clinicians attention.

    Article  CAS  PubMed  Google Scholar 

  4. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. American College of Obstetricians and Gynecologists., Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–31. https://doi.org/10.1097/01.AOG.0000437382.03963.88.

    Article  Google Scholar 

  5. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:e127–248. https://doi.org/10.1016/j.jacc.2017.11.006.

    Article  PubMed  Google Scholar 

  6. • Hu J, Li Y, Zhang B, Zheng T, Li J, Peng Y, et al. Impact of the 2017 ACC/AHA Guideline for high blood pressure on evaluating gestational hypertension–associated risks for newborns and mothers. Circ Res. 2019;125:184–94. https://doi.org/10.1161/CIRCRESAHA.119.314682The inclusion of ACC/AHA guidelines in the definition of hypertension during pregnancy will significantly increase the prevalence of gestational hypertension and chronic hypertension during pregnancy. More research is needed to identify the target blood pressure during pregnancy considering the risks and benefits of tight blood pressure control.

    Article  CAS  PubMed  Google Scholar 

  7. Hauspurg A, Sutton E, Catov J, Caritis S. Applying the new ACC/AHA aspirin effect on adverse pregnancy outcomes associated with stage 1 hypertension in a high-risk cohort. Hypertension. 2018;72:202–7. https://doi.org/10.1161/HYPERTENSIONAHA.118.11196.

    Article  CAS  PubMed  Google Scholar 

  8. Tesfalul M, Sperling J, Blat C, Parikh N, Velez JG, Zlatnik M, et al. Adverse perinatal outcomes associated with elevated blood pressure and stage 1 hypertension. AJOG. 2020;(1, Supplement):S92–3.

  9. Bateman BT, Shaw KM, Kuklina EV, Callaghan WM, Seely EW, Hernandez-Diaz S. Hypertesnion in women of reproductive age in the United States: NHANES 1999-2008. PLoS One. 2012;7(4):e36171. https://doi.org/10.1371/journal.pone.0036171.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. ACOG practice bulletin no. 203:chronic hypertension in pregnancy. Obstet Gynecol. 2019;133:e26–50. https://doi.org/10.1097/AOG.0000000000003020.

  11. Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG, et al. Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation. 2017;136:e393–423. https://doi.org/10.1161/CIR.0000000000000534.

    Article  PubMed  Google Scholar 

  12. Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol. 2015;125:5–12. https://doi.org/10.1097/AOG.0000000000000564.

    Article  PubMed  Google Scholar 

  13. Singh GK, Siahpush M, Liu L, Michelle A. Racial/ethnic, nativity, and sociodemographic disparities in maternal hypertension in the United States, 2014–2015. Int J Hypertens. 2018;2018:7897189–14. https://doi.org/10.1155/2018/7897189.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wolf M, Shah A, Jimenez-Kimble R, Sauk J, Ecker JL, Thadhani R. Differential risk of hypertensive disorders of pregnancy among Hispanic women. J Am Soc Nephrol. 2004;15(5):1330–8. https://doi.org/10.1097/01.asn.0000125615.35046.59.

    Article  PubMed  Google Scholar 

  15. Ying W, Catov JM, Ouyang P. Hypertensive disorders of pregnancy and future maternal cardiovascular risk. JAHA. 2018;7:e009382. https://doi.org/10.1161/JAHA.118.009382.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Veerbeek JH, Hermes W, Breimer AY, van Rijn BB, Koenen SV, Mol BW, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. Hypertension. 2015;65:600–6. https://doi.org/10.1161/HYPERTENSIONAHA.114.04850.

    Article  CAS  PubMed  Google Scholar 

  17. Veerbeek JH, Brouwers L, Koster MP, Koenen SV, van Vliet EO, Nikkels PG, et al. Spiral artery remodeling and maternal cardiovascular risk: the spiral artery remodeling (SPAR) study. J Hypertens. 2016;34:1570–7. https://doi.org/10.1097/HJH.0000000000000964.

    Article  CAS  PubMed  Google Scholar 

  18. Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286:H1389–93. https://doi.org/10.1152/ajpheart.00298.2003.

    Article  CAS  PubMed  Google Scholar 

  19. Estensen ME, Remme EW, Grindheim G, Smiseth OA, Segers P, Henriksen T, et al. Increased arterial stiffness in pre-eclamptic pregnancy at term and early and late postpartum: a combined echocardiographic and tonometric study. Am J Hypertens. 2013;26:549–56. https://doi.org/10.1093/ajh/hps067.

    Article  CAS  PubMed  Google Scholar 

  20. Kvehaugen AS, Dechend R, Ramstad HB, Troisi R, Fugelseth D, Staff AC. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension. 2011;58:63–9. https://doi.org/10.1161/HYPERTENSIONAHA.111.172387.

    Article  CAS  PubMed  Google Scholar 

  21. Fraser A, Nelson SM, Macdonald-Wallis C, Cherry L, Butler E, Sattar N, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation. 2012;125:1367–80. https://doi.org/10.1161/CIRCULATIONAHA.111.044784.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Cappell LC. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301. https://doi.org/10.1136/bmj.g2301.

    Article  PubMed  PubMed Central  Google Scholar 

  23. McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol. 1996;103:123–9. https://doi.org/10.1111/j.1471-0528.1996.tb09662.x.

    Article  CAS  PubMed  Google Scholar 

  24. Ananth CV, Peltier MR, Kinzler WL, Smulian JC, Vintzileos AM. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am J Obstet Gynecol. 2007;197:273.el–7. https://doi.org/10.1016/j.ajog.2007.05.047.

    Article  Google Scholar 

  25. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol. 2002;100:369–77. https://doi.org/10.1016/s0029-7844(02)02128-2.

    Article  PubMed  Google Scholar 

  26. Cain MA, Salemi JL, Tanner JP, Kirby RS, Salihu HM, Louis JM. Pregnancy as a window to future health: maternal placental syndromes and short-term cardiovascular outcomes. Am J Obstet Gynecol. 2016;215:484.e1–484.e14. https://doi.org/10.1016/j.ajog.2016.05.047.

    Article  Google Scholar 

  27. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28:1–19. https://doi.org/10.1007/s10654-013-9762-6.

    Article  PubMed  Google Scholar 

  28. Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2). https://doi.org/10.1161/CIRCOUTCOMES.116.003497.

  29. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53:944–51. https://doi.org/10.1161/HYPERTENSIONAHA.109.130765.

    Article  CAS  PubMed  Google Scholar 

  30. Mannisto T, Mendola P, Vaarasmaki M, Jarvelin MR, Hartikainen AL, Pouta A, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013;127:681–90. https://doi.org/10.1161/CIRCULATIONAHA.112.128751.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Riise HKR, Sulo G, Tell GS, Igland J, Nygard O, Iversen AC, et al. Association between gestational hypertension and risk of cardiovascular disease among 617 589 Norwegian women. J Am Heart Assoc. 2018;7:e008337. https://doi.org/10.1161/JAHA.117.008337.

    Article  PubMed  PubMed Central  Google Scholar 

  32. • Stuart JJ, Tanz LJ, Missmer SA, et al. Hypertensive disorders of pregnancy and maternal cardiovascular disease risk factor development: an observational cohort study. Ann Intern Med. 2018;169:224–32. https://doi.org/10.7326/M17-2740Hypertensive disorders of pregnancy have a negative impact on the long term cardiovascular health of women.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Muntner P, Carey RM, Jamerson K, Wright JT, Whelton PK. Rationale for ambulatory and home blood pressure monitoring thresholds in the 2017 American College of Cardiology/American Heart Association Guideline. Hypertension. 2019;73:33–8. https://doi.org/10.1161/HYPERTENSIONAHA.118.11946.

    Article  CAS  PubMed  Google Scholar 

  34. US Preventive Services Task Force. Screening for preeclampsia: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317(16):1661–7. https://doi.org/10.1001/jama.2017.3439.

    Article  Google Scholar 

  35. Peek M, Shennan A, Halligan A, Lambert PC, Taylor DJ, De Swiet M. Hypertension in pregnancy: which method of blood pressure measurement is most predictive of outcome. Obstet Gynecol. 1996;88(6):1030–3. https://doi.org/10.1016/S0029-7844(96)00350-X.

    Article  CAS  PubMed  Google Scholar 

  36. Wenger NK, Arnold A, Merz CNB, Cooper-DeHoff RM, Ferdinand KC, Fleg JL, et al. Hypertension across a woman’s life cycle. J Am Coll Cardiol. 2018;71(16):1797–813. https://doi.org/10.1016/j.jacc.2018.02.033.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Sibai BM, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension: National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998;339:667–71. https://doi.org/10.1056/NEJM199809033391004.

    Article  CAS  PubMed  Google Scholar 

  38. Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstrom M, et al. Predictive value of the sFlt-1:PIGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13–22. https://doi.org/10.1056/NEJMoa1414838.

    Article  CAS  PubMed  Google Scholar 

  39. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178:701–11. https://doi.org/10.1503/cmaj.070430.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco MC, et al. Aspirin versus placebo in pregnancies at high-risk for preterm preeclampsia. N Engl J Med. 2017;377:613–22. https://doi.org/10.1056/NEJMoa1704559.

    Article  CAS  PubMed  Google Scholar 

  41. Committee Opinion No ACOG. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132(1):e44–52. https://doi.org/10.1097/AOG.0000000000002708.

    Article  Google Scholar 

  42. LeFevre ML, on behalf of the U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;161:819–26. https://doi.org/10.7326/M14-1884.

    Article  PubMed  Google Scholar 

  43. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Tortoni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014;6:CD001059. https://doi.org/10.1002/14651858.CD001059.pub4.

    Article  Google Scholar 

  44. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87–92. https://doi.org/10.1016/s0140-6736(98)08049-0.

    Article  Google Scholar 

  45. Magee LA, vonDadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:407–17. https://doi.org/10.1056/NEJMoa1404595.

    Article  CAS  PubMed  Google Scholar 

  46. Chronic Hypertension and Pregnancy (CHAP) Project (CHAP). Ongoing clinical trial. https://clinicaltrials.gov/ct2/show/NCT02299414.

  47. Weiss JL, Malone FD, Emig D, Ball RH, Nyberg DA, Comstock CH, et al. Obesity, obstetric complications and cesarean delivery rate-a population-based screening study. Am J Obstet Gynecol. 2004;190:1091–7. https://doi.org/10.1016/j.ajog.2003.09.058.

    Article  PubMed  Google Scholar 

  48. O’Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;14:368–74. https://doi.org/10.1097/00001648-200305000-00020.

    Article  PubMed  Google Scholar 

  49. Dodd JM, Turnbull D, McPhee AJ, Deussen AR, Grivell RM, Yelland LN, et al. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ. 2014;348:g1285. https://doi.org/10.1136/bmj.g1285.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Leddy MA, Power ML, Schulkin J. The impact of maternal obesity on maternal and fetal health. Rev. Obstet Gynecol. 2008;1:170–8. https://doi.org/10.1016/j.mce.2015.07.028.

    Article  CAS  Google Scholar 

  51. Lindheimer MD, Taler SJ, Cunningham FG. ASH position paper: hypertension in pregnancy. J Clin Hypertens (Greenwich). 2009;11:214–25. https://doi.org/10.1111/j.1751-7176.2009.00085.x.

    Article  Google Scholar 

  52. Brown CM, Garovic VD. Drug treatment of hypertension in pregnancy. Drugs. 2014;74(3):283–96. https://doi.org/10.1007/s40265-014-0187-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Emory University School of Medicine, 101 Woodruff Circle, Suite 319, Atlanta, GA, 30322, USA

    Akanksha Agrawal & Nanette K. Wenger

Authors
  1. Akanksha Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nanette K. Wenger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Akanksha Agrawal.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Guidelines/Clinical Trials/Meta-Analysis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agrawal, A., Wenger, N.K. Hypertension During Pregnancy. Curr Hypertens Rep 22, 64 (2020). https://doi.org/10.1007/s11906-020-01070-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-020-01070-0

Keywords

Search

Navigation